Real-world evaluation of early use of ESkeTAmine for functional Remission in MDD-TRD paTients in Italy. RESTART

Copyright © 2025 FULLCRO S.R.L. - TUTTI I DIRITTI RISERVATI
per contatti riguardanti lo Studio RESTART RESTART@fullcro.org